We are live on ! Find out more
JSAM

J. Safra Asset Management Portfolio holdings

AUM $2.17B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-3.05%
1 Year Est. Return
+29.66%
3 Year Est. Return
+84.26%
5 Year Est. Return
+107.54%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
+$354K
Cap. Flow
+$54.9M
Cap. Flow %
4.46%
Top 10 Hldgs %
68.41%
Holding
404
New
63
Increased
215
Reduced
43
Closed
59

Top Buys

Rank Stock Value
1
AAXJ icon
iShares MSCI All Country Asia ex Japan ETF
AAXJ
+$55.8M
2
MAGS icon
Listed Funds Trust Roundhill Magnificent Seven ETF
MAGS
+$19.1M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$8.05M
4
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$4.87M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$4.77M

Top Sells

Rank Stock Value
1
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$5.73M
3
IWB icon
iShares Russell 1000 ETF
IWB
+$3.56M
4
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$2.37M
5
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$1.3M

Sector Composition

Rank Sector Weight
1 Technology 2.22%
2 Communication Services 1.07%
3 Financials 0.88%
4 Consumer Discretionary 0.82%
5 Healthcare 0.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IT icon
301
Gartner
IT
$11.8B
$7.55K ﹤0.01%
18
-20
-53% -$9.86K
PRVA icon
302
Privia Health
PRVA
$2.81B
$6.94K ﹤0.01%
309
+249
+415% +$5.79K
AEO icon
303
American Eagle Outfitters
AEO
$2.91B
$6.79K ﹤0.01%
584
+24
+4% +$343
FNWB icon
304
First Northwest Bancorp
FNWB
$106M
$6.67K ﹤0.01%
657
+34
+5% +$360
LEGN icon
305
Legend Biotech
LEGN
$4.22B
$6.51K ﹤0.01%
192
+164
+586% +$5.88K
RCKY icon
306
Rocky Brands
RCKY
$355M
$6.15K ﹤0.01%
354
+13
+4% +$284
ALHC icon
307
Alignment Healthcare
ALHC
$2.74B
$6.11K ﹤0.01%
328
+277
+543% +$4.13K
CLDX icon
308
Celldex Therapeutics
CLDX
$3.48B
$5.99K ﹤0.01%
330
+18
+6% +$402
CAL icon
309
Caleres
CAL
$475M
$5.48K ﹤0.01%
318
+14
+5% +$252
SGRY icon
310
Surgery Partners
SGRY
$1.96B
$5.25K ﹤0.01%
221
+185
+514% +$4.38K
RPRX icon
311
Royalty Pharma
RPRX
$25.7B
$5.14K ﹤0.01%
165
+139
+535% +$4.41K
MOH icon
312
Molina Healthcare
MOH
$10.2B
$4.94K ﹤0.01%
15
+12
+400% +$3.63K
BTSG icon
313
BrightSpring Health Services
BTSG
$11.5B
$4.45K ﹤0.01%
246
+207
+531% +$4.06K
REGN icon
314
Regeneron Pharmaceuticals
REGN
$82.1B
$4.44K ﹤0.01%
7
+5
+250% +$3.44K
PRCT icon
315
Procept Biorobotics
PRCT
$1.31B
$3.26K ﹤0.01%
56
+47
+522% +$3.21K
LFST icon
316
Lifestance Health
LFST
$4.39B
$3.21K ﹤0.01%
482
+404
+518% +$3.07K
MRUS
317
DELISTED
Merus
MRUS
$3.07K ﹤0.01%
73
+65
+813% +$2.83K
XENE icon
318
Xenon Pharmaceuticals
XENE
$6.11B
$2.82K ﹤0.01%
84
+73
+664% +$2.77K
ACLX
319
DELISTED
Arcellx
ACLX
$2.62K ﹤0.01%
40
+35
+700% +$2.37K
PHR icon
320
Phreesia
PHR
$758M
$2.5K ﹤0.01%
98
+82
+513% +$2.23K
MASI
321
DELISTED
Masimo
MASI
$2.5K ﹤0.01%
15
– –
ONC
322
BeOne Medicines Ltd
ONC
$40.6B
$2.45K ﹤0.01%
+9
New +$2.1K
VRDN icon
323
Viridian Therapeutics
VRDN
$2.6B
$2.43K ﹤0.01%
180
+159
+757% +$2.71K
CRNX icon
324
Crinetics Pharmaceuticals
CRNX
$8.95B
$2.42K ﹤0.01%
72
+65
+929% +$2.43K
TXG icon
325
10x Genomics
TXG
$7.62B
$2.24K ﹤0.01%
257
+218
+559% +$2.75K
11 12
13
14 15

Similar funds

ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

J. Safra Asset Management's Q1 2025 Portfolio in Review

As of Q1 2025, J. Safra Asset Management held 404 positions worth $1.23B, up 0.03% from $1.23B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

J. Safra Asset Management deployed $54.9M of net new capital in Q1 2025, opening 63 new positions and adding to 215 existing holdings. Its largest new stake was iShares MSCI All Country Asia ex Japan ETF: 754,260 shares worth $55.8M.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 1.7% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was iShares Core S&P Small-Cap ETF, an estimated $73.5M trimmed.

  • J. Safra Asset Management's largest Q1 2025 buy was iShares MSCI All Country Asia ex Japan ETF: 754,260 shares worth $55.8M.
  • J. Safra Asset Management added most to Listed Funds Trust Roundhill Magnificent Seven ETF in Q1 2025, an estimated $19.1M increase.
  • J. Safra Asset Management's biggest Q1 2025 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $73.5M.
  • J. Safra Asset Management fully exited Vanguard S&P 500 ETF in Q1 2025, selling an estimated $5.73M.
  • J. Safra Asset Management's ten largest holdings make up 68% of its $1.23B portfolio in Q1 2025.
  • J. Safra Asset Management opened 63 new positions and closed 59 in Q1 2025.
  • J. Safra Asset Management's portfolio value rose 0.03% quarter-over-quarter to $1.23B.

Based on J. Safra Asset Management's 13F filing for Q1 2025, filed 25 Apr 2025.